|
|
| (10 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| | __NOTOC__ |
| '''For patient information click [[Radiation injury (patient information)|here]]''' | | '''For patient information click [[Radiation injury (patient information)|here]]''' |
| {{Infobox_Disease | | | {{Infobox_Disease | |
| Line 6: |
Line 7: |
| }} | | }} |
| {{Radiation injury}} | | {{Radiation injury}} |
| {{CMG}}; {{AE}} {{CZ}} | | {{CMG}}; {{AE}} {{CZ}}; {{Ochuko}} |
|
| |
|
| ==Patient Management== | | ==[[Radiation injury overview|Overview]]== |
|
| |
|
| ===Initial Treatment=== | | ==[[Radiation injury classification|Classification]]== |
|
| |
|
| Localized injuries should be treated symptomatically as they occur, and radiation injury experts should be consulted for detailed information. Such information can be obtained from the Radiation Emergency Assistance Center/Training Site (REAC/TS) at www.orau.gov/reacts/ or (865) 576-1005.
| | ==[[Radiation injury pathophysiology|Pathophysiology]]== |
|
| |
|
| As with ARS, if the patient also has other trauma, wounds should be closed, burns covered, fractures reduced, surgical stabilization performed, and definitive treatment given within the first 48 hours after injury. After 48 hours, surgical interventions should be delayed until hematopoietic recovery has occurred.
| | ==[[Radiation injury causes|Causes]]== |
|
| |
|
| A baseline CBC and differential should be taken and repeated in 24 hours. Because cutaneous radiation injury is cyclic, areas of early erythema should be noted and recorded. These areas should also be sketched and photographed, if possible, ensuring that the date and time are recorded. The following should be initiated as indicated:
| | ==[[Radiation injury differential diagnosis|Differentiating Radiation Injury from other Diseases]]== |
|
| |
|
| *Supportive care in a clean environment (a burn unit if one is available)
| | ==[[Radiation injury risk factors|Risk Factors]]== |
| *Prevention and treatment of infections
| |
| *Use of the following:
| |
| *Medications to reduce inflammation, inhibit protealysis, relieve pain, stimulate regeneration, and improve circulation
| |
| *Anticoagulant agents for widespread and deep injury
| |
| *Pain management
| |
| *Psychological support
| |
|
| |
|
| ===Recommendations for Treatment by Stage=== | | ==[[Radiation injury screening|Screening]]== |
|
| |
|
| The following recommendations for treatment by stage of the illness were obtained by summarizing recommendations from Ricks et al. (226) and Gusev et al. (231), but they do not represent official recommendations of CDC.
| | ==[[Radiation injury natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
|
| |
|
| *Prodromal Stage —Use antihistamines and topical antipruriginous preparations, which act against itch and also might prevent or attenuate initiation of the cycle that leads to the manifestation stage. Anti-inflammatory medications such as corticosteroids and topical creams, as well as slight sedatives, may prove useful.
| | ==[[Radiation injury diagnosis|Diagnosis]]== |
| | [[Radiation injury history and symptoms|History and Symptoms]] | [[Radiation injury physical examination|Physical Examination]] | [[Radiation injury laboratory findings|Laboratory Findings]] | [[Radiation injury MRI|MRI]] | [[Radiation injury other imaging findings|Other Imaging Findings]] | [[Radiation injury other diagnostic studies|Other Diagnostic Studies]] |
|
| |
|
| *Latent Stage —Continue anti-inflammatory medications and sedatives. At midstage, use proteolysis inhibitors, such as Gordox®.
| | ==Treatment== |
| | [[Radiation injury medical therapy|Medical Therapy]] | [[Radiation injury surgery|Surgery]] | [[Radiation injury primary prevention|Primary Prevention]] | [[Radiation injury cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Radiation injury future or investigational therapies|Future or Investigational Therapies]] |
|
| |
|
| *Manifestation Stage —Use repeated swabs, antibiotic prophylaxis, and anti-inflammatory medications, such as Lioxasol®, to reduce bacterial, fungal, and viral infections
| | ==Case Studies== |
| | | [[Radiation injury case study one|Case #1]] |
| :* Apply topical ointments containing corticosteroids along with locally acting antibiotics and vitamins.
| |
| :* Stimulate regeneration of DNA by using Lioxasol® and later, when regeneration has started, biogenic drugs, such as Actovegin® and Solcoseril®.
| |
| :* Stimulate blood supply in third or fourth week using Pentoxifylline® (contraindicated for patients with atherosclerotic heart disease).
| |
| :* Puncture blisters if they are sterile, but do not remove them as long as they are intact.
| |
| :* Stay alert for wound infection. Antibiotic therapy should be considered according to the individual patient's condition.
| |
| :* Treat pain according to the individual patient's condition. Pain relief is very difficult and is the most demanding part of the therapeutic process.
| |
| :* Debride areas of necrosis thoroughly but cautiously.
| |
| | |
| ===Treatment of Late Effects===
| |
| | |
| After immediate treatment of radiation injury, an often long and painful process of healing will ensue. The most important concerns are the following:
| |
| | |
| *Pain management
| |
| *Fibrosis or late ulcers
| |
| Note : Use of medication to stimulate vascularization, inhibit infection, and reduce fibrosis may be effective. Examples include Pentoxifylline®, vitamin E, and interferon gamma.
| |
| *Psychological effects, such as posttraumatic stress disorder
| |
| *Possibility of increased risk of skin cancer later in life
| |
| | |
| Patient Management
| |
| | |
| Triage: If radiation exposure is suspected:
| |
| | |
| * Secure ABCs (airway, breathing, circulation) and physiologic monitoring (blood pressure, blood gases, electrolyte and urine output) as appropriate.
| |
| * Treat major trauma, burns and respiratory injury if evident.
| |
| * In addition to the blood samples required to address the trauma, obtain blood samples for CBC (complete blood count), with attention to lymphocyte count, and HLA (human leukocyte antigen) typing prior to any initial transfusion and at periodic intervals following transfusion.
| |
| * Treat contamination as needed.
| |
| * If exposure occurred within 8 to 12 hours, repeat CBC, with attention to lymphocyte count, 2 or 3 more times (approximately every 2 to 3 hours) to assess lymphocyte depletion.
| |
| | |
| ===Diagnosis===
| |
| The diagnosis of ARS can be difficult to make because ARS causes no unique disease. Also, depending on the dose, the prodromal stage may not occur for hours or days after exposure, or the patient may already be in the latent stage by the time they receive treatment, in which case the patient may appear and feel well when first assessed.
| |
| | |
| If a patient received more than 0.05 Gy (5 rads) and three or four CBCs are taken within 8 to 12 hours of the exposure, a quick estimate of the dose can be made (see Ricks, et. al. for details). If these initial blood counts are not taken, the dose can still be estimated by using CBC results over the first few days. It would be best to have radiation dosimetrists conduct the dose assessment, if possible.
| |
| | |
| If a patient is known to have been or suspected of having been exposed to a large radiation dose, draw blood for CBC analysis with special attention to the lymphocyte count, every 2 to 3 hours during the first 8 hours after exposure (and every 4 to 6 hours for the next 2 days). Observe the patient during this time for symptoms and consult with radiation experts before ruling out ARS.
| |
| | |
| If no radiation exposure is initially suspected, you may consider ARS in the differential diagnosis if a history exists of nausea and vomiting that is unexplained by other causes. Other indications are bleeding, epilation, or white blood count (WBC) and platelet counts abnormally low a few days or weeks after unexplained nausea and vomiting. Again, consider CBC and chromosome analysis and consultation with radiation experts to confirm diagnosis.
| |
| | |
| ===Initial Treatment and Diagnostic Evaluation===
| |
| | |
| Treat vomiting, and repeat CBC analysis, with special attention to the lymphocyte count, every 2 to 3 hours for the first 8 to 12 hours following exposure (and every 4 to 6 hours for the following 2 or 3 days). Sequential changes in absolute lymphocyte counts over time are demonstrated below in the Andrews Lymphocyte Nomogram (see Figure 1). Precisely record all clinical symptoms, particularly nausea, vomiting, diarrhea, and itching, reddening or blistering of the skin. Be sure to include time of onset.
| |
| | |
| [[Image:radiation_graph.gif|left|thumb|300px|Figure 1. Andrews Lymphocyte Nomogram (From Andrews GA, Auxier JA, Lushbaugh CC. The Importance of Dosimetry to the Medical Management of Persons Exposed to High Levels of Radiation. In Personal Dosimetry for Radiation Accidents. Vienna : International Atomic Energy Agency; 1965)]]
| |
| <br clear="left"/>
| |
| Note and record areas of erythema. If possible, take color photographs of suspected radiation skin damage. Consider tissue, blood typing, and initiating viral prophylaxis. Promptly consult with radiation, hematology, and radiotherapy experts about dosimetry, prognosis, and treatment options. Call the Radiation Emergency Assistance Center/Training Site (REAC/TS) at (865) 576-3131 (M-F, 8 am to 4:30 am EST) or (865) 576-1005 (after hours) to record the incident in the Radiation Accident Registry System.
| |
| | |
| ===After consultation, begin the following (as indicated):===
| |
| | |
| * supportive care in a clean environment (if available, the use of a burn unit may be quite effective)
| |
| * prevention and treatment of infections
| |
| * stimulation of hematopoiesis by use of growth factors
| |
| * stem cell transfusions or platelet transfusions (if platelet count is too low)
| |
| * psychological support
| |
| * careful observation for erythema (document locations), hair loss, skin injury, mucositis, parotitis, weight loss, or fever
| |
| * confirmation of initial dose estimate using chromosome aberration cytogenetic bioassay when possible. Although resource intensive, this is the best method of dose assessment following acute exposures.
| |
| * consultation with experts in radiation accident management.
| |
| | |
| ==Source==
| |
|
| |
|
| | ==External Links== |
| *[http://www.bt.cdc.gov/radiation/arsphysicianfactsheet.asp#table1 Centers for Disease Control and Prevention] | | *[http://www.bt.cdc.gov/radiation/arsphysicianfactsheet.asp#table1 Centers for Disease Control and Prevention] |
|
| |
| ==References==
| |
|
| |
| * Berger ME, O’Hare FM Jr, Ricks RC, editors. The Medical Basis for Radiation Accident Preparedness: The Clinical Care of Victims. REAC/TS Conference on the Medical Basis for Radiation Accident Preparedness. New York : Parthenon Publishing; 2002.
| |
|
| |
| * Gusev IA , Guskova AK , Mettler FA Jr, editors. Medical Management of Radiation Accidents, 2 nd ed., New York : CRC Press, Inc.; 2001.
| |
|
| |
| * Jarrett DG. Medical Management of Radiological Casualties Handbook, 1 st ed. Bethesda , Maryland : Armed Forces Radiobiology Research Institute (AFRRI); 1999.
| |
|
| |
| * LaTorre TE. Primer of Medical Radiobiology, 2 nd ed. Chicago : Year Book Medical Publishers, Inc.; 1989.
| |
|
| |
| * National Council on Radiation Protection and Measurements (NCRP). Management of Terrorist Events Involving Radioactive Material, NCRP Report No. 138. Bethesda , Maryland : NCRP; 2001.
| |
|
| |
| * Prasad KN. Handbook of Radiobiology, 2 nd ed. New York : CRC Press, Inc.; 1995.
| |
|
| |
| ==Additional Resources==
| |
|
| |
| *Michihiko Hachiya, ''Hiroshima Diary'' (Chapel Hill: University of North Carolina, 1955), ISBN 0-8078-4547-7.
| |
| *John Hersey, ''Hiroshima'' (New York: Vintage, 1946, 1985 new chapter), ISBN 0-679-72103-7.
| |
| *Ibuse Masuji, ''Black Rain'' (1969) ISBN 0-87011-364-X
| |
| *Ernest J. Sternglass, ''Secret Fallout: low-level radiation from Hiroshima to Three-Mile Island'' (1981) ISBN 0-07-061242-0 ([http://www.ratical.org/radiation/SecretFallout/ online])
| |
| *Norman Solomon, Harvey Wasserman ''Killing Our Own: The Disaster of America's Experience with Atomic Radiation, 1945-1982'', New York: Dell, 1982. ISBN 0-385-28537-X, ISBN 0-385-28536-1, ISBN 0-440-04567-3 ([http://www.ratical.org/radiation/KillingOurOwn/ online])
| |
| *George N. Hamawy, ''A Brief Introduction to Radiation Safety'' (Tucson, Arizona: Wheatmark, 2007), [http://amzn.to/ftiS7P ISBN 1587368935]
| |
|
| |
| ==External links==
| |
| * [http://bjr.birjournals.org/cgi/reprint/Supplement_27/1/41.pdf Radiation accidents with multi-organ failure in the United States] | | * [http://bjr.birjournals.org/cgi/reprint/Supplement_27/1/41.pdf Radiation accidents with multi-organ failure in the United States] |
| * [http://www.johnstonsarchive.net/nuclear/radevents/radaccidents.html List of radiation accidents and other events causing radiation casualties] | | * [http://www.johnstonsarchive.net/nuclear/radevents/radaccidents.html List of radiation accidents and other events causing radiation casualties] |
| Line 125: |
Line 41: |
| * [http://www.bt.cdc.gov/radiation/arsphysicianfactsheet.asp The Center for Disease Control's fact sheet on Acute Radiation Syndrome] | | * [http://www.bt.cdc.gov/radiation/arsphysicianfactsheet.asp The Center for Disease Control's fact sheet on Acute Radiation Syndrome] |
| * [http://courses.cs.vt.edu/~cs3604/lib/Therac_25/Therac_1.html Therac-25 computerized radiation therapy machine accidents] | | * [http://courses.cs.vt.edu/~cs3604/lib/Therac_25/Therac_1.html Therac-25 computerized radiation therapy machine accidents] |
|
| |
|
| |
|
| {{Consequences of external causes}} | | {{Consequences of external causes}} |
|
| |
|
| |
|
| [[Category:Emergency medicine]] | | [[Category:Emergency medicine]] |
